Subsequent results showed that overexpression of FGD5-AS1 results in decreased ALP activity and calcium nodules, as well as expression of RUNX2 and OPN, thereby alleviating CAVD. Here, RUNX2 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.